フォロー
Ashlee Clark
Ashlee Clark
確認したメール アドレス: monash.edu
タイトル
引用先
引用先
Suppressing fatty acid uptake has therapeutic effects in preclinical models of prostate cancer
MJ Watt, AK Clark, LA Selth, VR Haynes, N Lister, R Rebello, LH Porter, ...
Science translational medicine 11 (478), eaau5758, 2019
2572019
Identification of metabolically distinct adipocyte progenitor cells in human adipose tissues
A Raajendiran, G Ooi, J Bayliss, PE O’Brien, RB Schittenhelm, AK Clark, ...
Cell reports 27 (5), 1528-1540. e7, 2019
1192019
Patient-derived models of abiraterone-and enzalutamide-resistant prostate cancer reveal sensitivity to ribosome-directed therapy
MG Lawrence, D Obinata, S Sandhu, LA Selth, SQ Wong, LH Porter, ...
European urology 74 (5), 562-572, 2018
932018
The dual inhibition of RNA Pol I transcription and PIM kinase as a new therapeutic approach to treat advanced prostate cancer
RJ Rebello, E Kusnadi, DP Cameron, HB Pearson, A Lesmana, JR Devlin, ...
Clinical Cancer Research 22 (22), 5539-5552, 2016
782016
A bioengineered microenvironment to quantitatively measure the tumorigenic properties of cancer-associated fibroblasts in human prostate cancer
AK Clark, AV Taubenberger, RA Taylor, B Niranjan, ZY Chea, E Zotenko, ...
Biomaterials 34 (20), 4777-4785, 2013
762013
The MURAL collection of prostate cancer patient-derived xenografts enables discovery through preclinical models of uro-oncology
GP Risbridger, AK Clark, LH Porter, R Toivanen, A Bakshi, NL Lister, ...
Nature communications 12 (1), 5049, 2021
402021
A rare castration‐resistant progenitor cell population is highly enriched in Pten‐null prostate tumours
L Sackmann Sala, F Boutillon, G Menara, A De Goyon‐Pélard, ...
The Journal of pathology 243 (1), 51-64, 2017
322017
Obesity does not promote tumorigenesis of localized patient-derived prostate cancer xenografts
JCY Lo, AK Clark, N Ascui, M Frydenberg, GP Risbridger, RA Taylor, ...
Oncotarget 7 (30), 47650, 2016
232016
Establishing a cryopreservation protocol for patient‐derived xenografts of prostate cancer
LH Porter, MG Lawrence, H Wang, AK Clark, A Bakshi, D Obinata, ...
The Prostate 79 (11), 1326-1337, 2019
182019
Androgen receptor enhancer amplification in matched patient‐derived xenografts of primary and castrate‐resistant prostate cancer
LH Porter, A Bakshi, D Pook, A Clark, D Clouston, J Kourambas, ...
The Journal of pathology 254 (2), 121-134, 2021
132021
Early intervention exercise training does not delay prostate cancer progression in Pten−/− mice
RA Taylor, SG Farrelly, AK Clark, MJ Watt
The Prostate 80 (11), 906-914, 2020
62020
Suppressing fatty acid uptake has therapeutic effects in preclinical models of prostate cancer. Sci Transl Med 11: eaau5758
MJ Watt, AK Clark, LA Selth, VR Haynes, N Lister, R Rebello, LH Porter, ...
62019
Suppressing fatty acid uptake has therapeutic effects in preclinical models of prostate cancer. Sci Transl Med. 2019; 11
MJ Watt, AK Clark, LA Selth, VR Haynes, N Lister, R Rebello
6
The future of patient-derived xenografts in prostate cancer research
MG Lawrence, RA Taylor, GB Cuffe, LS Ang, AK Clark, DL Goode, ...
Nature Reviews Urology 20 (6), 371-384, 2023
32023
Potent stimulation of the androgen receptor instigates a viral mimicry response in prostate cancer
M Alizadeh-Ghodsi, KL Owen, SL Townley, D Zanker, SPG Rollin, ...
Cancer Research Communications 2 (7), 706-724, 2022
32022
Mast cell interactions at tumour interface drive progression in human prostate cancer
G Risbridger, S Ellem, R Taylor, M Frydenberg, D Pook, J Pedersen, ...
Endocrine Abstracts 35, 2014
12014
Defining focal neuroendocrine differentiation as a transcriptionally distinct form of prostate cancer pathology characterized by the expression of androgen receptors
S Keerthikumar, A Clark, H Wang, B Phipson, A Bakshi, A Ryan, ...
2024
Defining the challenges and opportunities for using patient‐derived models in prostate cancer research
WN Brennen, C Le Magnen, S Karkampouna, N Anselmino, N Bock, ...
The Prostate, 2024
2024
Defining focal neuroendocrine differentiation as a transcriptionally distinct form of prostate cancer pathology characterized by the expression of androgen receptors
R Quezada Urban, S Keerthikumar, A Clark, H Wang, B Phipson, ...
bioRxiv, 2024.03. 17.585125, 2024
2024
Abstract PR006: PMR-116, a novel inhibitor of ribosome biogenesis with antitumor activity in preclinical models of prostate cancer
A Huglo, S Hedwards, M Lawrence, R Rebello, A Clark, G Risbridger, ...
Cancer Research 83 (11_Supplement), PR006-PR006, 2023
2023
現在システムで処理を実行できません。しばらくしてからもう一度お試しください。
論文 1–20